Carmignac Gestion Lantheus Holdings, Inc. Transaction History
Carmignac Gestion
- $5.85 Billion
- Q1 2025
A detailed history of Carmignac Gestion transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Carmignac Gestion holds 190,500 shares of LNTH stock, worth $10.5 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
190,500
Previous 232,700
18.13%
Holding current value
$10.5 Million
Previous $20.8 Million
10.69%
% of portfolio
0.32%
Previous 0.34%
Shares
4 transactions
Others Institutions Holding LNTH
# of Institutions
550Shares Held
77.1MCall Options Held
472KPut Options Held
186K-
Black Rock Inc. New York, NY8.6MShares$472 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$384 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.51MShares$357 Million0.36% of portfolio
-
Farallon Capital Management LLC San Francisco, CA6.02MShares$330 Million3.38% of portfolio
-
State Street Corp Boston, MA2.64MShares$145 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.77B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...